Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Strategies for Structural Modification of Small Molecules to Improve Blood–Brain Barrier Penetration: A Recent Perspective
Baichen Xiong, Yuanyuan Wang, Ying Chen, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13152-13173
Closed Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system
Chang Wang, Yonger Xue, Tamara Markovic, et al.
Nature Materials (2025)
Closed Access | Times Cited: 6
Applications of hydrogels and nanoparticles in the treatment of traumatic brain injury
Jiaying Shi, Jiajia Tang, Xu Jin, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 12
Open Access | Times Cited: 2
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Qiu-Qin Han, Weidong Le
Neuroscience Bulletin (2023) Vol. 39, Iss. 5, pp. 832-844
Open Access | Times Cited: 38
Explaining Blood–Brain Barrier Permeability of Small Molecules by Integrated Analysis of Different Transport Mechanisms
Fleur M.G. Cornelissen, Greta Markert, Ghislaine Deutsch, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 11, pp. 7253-7267
Open Access | Times Cited: 24
The risk associated with organophosphorus nerve agents: from their discovery to their unavoidable threat, current medical countermeasures and perspectives
Camille Voros, José Dias, Christopher M. Timperley, et al.
Chemico-Biological Interactions (2024) Vol. 395, pp. 110973-110973
Open Access | Times Cited: 15
The Impact of C-3 Side Chain Modifications on Kynurenic Acid: A Behavioral Analysis of Its Analogs in the Motor Domain
Diána Martos, Bálint Lőrinczi, István Szatmári, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3394-3394
Open Access | Times Cited: 12
Myricetin Oligomer Triggers Multi-Receptor Mediated Penetration and Autophagic Restoration of Blood-Brain Barrier for Ischemic Stroke Treatment
Lei Liu, Zhifang Ma, Qiaoyi Han, et al.
ACS Nano (2024) Vol. 18, Iss. 14, pp. 9895-9916
Closed Access | Times Cited: 12
Direct Synthesis of α- and β-2′-Deoxynucleosides with Stereodirecting Phosphine Oxide via Remote Participation
Xintong Tang, Yueer Zhou, Yingjie Wang, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 12, pp. 8768-8779
Closed Access | Times Cited: 9
Computational Modeling of Pharmaceuticals with an Emphasis on Crossing the Blood–Brain Barrier
Patrícia Alencar Alves, Luana Cristina Camargo, Gabriel Souza, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 217-217
Open Access | Times Cited: 1
Challenges and Material Innovations in Drug Delivery to Central Nervous System Tumors
Zhenyu Gong, Dairan Zhou, Dejun Wu, et al.
Biomaterials (2025) Vol. 319, pp. 123180-123180
Closed Access | Times Cited: 1
Is Cocaine Protonated When it Binds to the Dopamine Transporter?
Marie L. Gram, Julia Warren, Emilie L. Madsen, et al.
JACS Au (2025) Vol. 5, Iss. 3, pp. 1157-1172
Open Access | Times Cited: 1
Extracellular Vesicles: A Review of Their Therapeutic Potentials, Sources, Biodistribution, and Administration Routes
Xiaorong Su, Hongxiang Wang, Qiubai Li, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3175-3199
Open Access | Times Cited: 1
Recent advances in small molecular near-infrared fluorescence probes for a targeted diagnosis of the Alzheimer disease
Yue Liu, Danping Zhuang, Jingjing Wang, et al.
The Analyst (2022) Vol. 147, Iss. 21, pp. 4701-4723
Closed Access | Times Cited: 35
Current Chemical, Biological, and Physiological Views in the Development of Successful Brain-Targeted Pharmaceutics
Magdalena Markowicz-Piasecka, Agata Markiewicz, Patrycja Darłak, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 3, pp. 942-976
Open Access | Times Cited: 31
A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatment
Diana Pelizzari‐Raymundo, Dimitrios Doultsinos, Raphaël Pineau, et al.
iScience (2023) Vol. 26, Iss. 5, pp. 106687-106687
Open Access | Times Cited: 18
PROTACs in the Management of Prostate Cancer
Yedla Poornachandra, Ahmad O. Babalghith, Vindhya Vasini Andra, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3698-3698
Open Access | Times Cited: 18
Strategies for designing novel positron emission tomography (PET) radiotracers to cross the blood–brain barrier
Anton Lindberg, Melissa Chassé, Cassis Varlow, et al.
Journal of Labelled Compounds and Radiopharmaceuticals (2023) Vol. 66, Iss. 9, pp. 205-221
Closed Access | Times Cited: 17
Unveiling the role of histone deacetylases in neurological diseases: focus on epilepsy
Danfeng Cao, Xinyu Zhou, Qian Guo, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer’s disease
Chuanyu Yu, Xueyan Liu, Bingxiang Ma, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 6
Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases
Qi Li, Qinghong Liao, Shulei Qi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116386-116386
Closed Access | Times Cited: 6
Phytotherapeutic options for the treatment of epilepsy: pharmacology, targets, and mechanism of action
Abdul Waris, Ata Ullah, Muhammad Asim, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors
Mitchell H. Keylor, Anmol Gulati, Solomon D. Kattar, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 1, pp. 838-856
Closed Access | Times Cited: 36
Perspectives and new aspects of histone deacetylase inhibitors in the therapy of CNS diseases
Bo Han, Mengfei Wang, Jiayi Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115613-115613
Closed Access | Times Cited: 16
Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics
Daniil Sokolov, Neha Sharda, Aindrila Banerjee, et al.
Current Pharmaceutical Design (2023) Vol. 30, Iss. 1, pp. 31-47
Closed Access | Times Cited: 15
Synthesis, computational and antimicrobial study of 2-(2-Hydrazinyl)thiazole derivatives
Rahul A. Shinde, Vishnu A. Adole, Bapu S. Jagdale
Journal of Molecular Structure (2023) Vol. 1300, pp. 137096-137096
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top